Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food effect study of resminostat in healthy volunteers
jRCT2071210134Phase 1Completed
- Sponsor
- Yakult Honsha
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Resminostat in cutaneous T-cell lymphoma (CTCL) (2 arms), sponsored by Yakult Honsha. Primary endpoint: Pharmacokinetic parameters of resminostat. Started Apr 2022; status: completed.
02
Drugs
Resminostat
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on jRCT2071210134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210134.